Results 41 to 50 of about 19,734 (192)

Fucoidan alleviates the hepatorenal syndrome through inhibition organic solute transporter α/β to reduce bile acids reabsorption

Current Research in Pharmacology and Drug Discovery, 2023
The high levels of bile acids are a critical factor in hepatorenal syndrome. Organic solute transporter α/β (Ostα/β) participate in bile acids reabsorption in the kidney.
Xiaojuan Zhao, Ting Yang, Jiayan Zhou, Yanli Chen, Qian Shen, Jiankang Zhang, Qianqian Qiu   +6 more
doaj   +1 more source

Vasoconstrictors in hepatorenal syndrome – A critical review

Annals of Hepatology, 2019
Hepatorenal syndrome has the worst prognosis among causes of acute kidney injury in cirrhotic patients. Its definitive treatment is liver transplantation.
Ângelo Z. Mattos, Fernando C. Schacher, Angelo A. Mattos   +2 more
doaj   +1 more source

Recovery from Hepatorenal Syndrome after Orthotopic Liver Transplantation [PDF]

, 1973
Three patients with progressive renal failure and advanced hepatic insufficiency due to cirrhosis of the liver underwent orthotopic liver transplantation.
Berk, Berkowitz, Berkowitz, Charles W. Putnam, Fred H. Katz, Jacques L. Corman, Makoto Ishikawa, Mordecai M. Popovtzer, Shunzaburo Iwatsuki, Thomas E. Starzl   +9 more
core   +1 more source

Hepatorenal Syndrome in the Emergency Department: A Case Report

International Journal of Medical Students, 2014
Background: Hepatorenal syndrome is a condition where there is functional renal failure in a background of liver disease. It is relatively common in patients with liver cirrhosis and is associated with a high mortality rate if untreated.
Win Jim Tan, Mohan Tiruchittampalam
doaj   +1 more source

Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older

Annals of Hepatology, 2023
Introduction and Objectives: Clinical data for older patients with advanced liver disease are limited. This post hoc analysis evaluated the efficacy and safety of terlipressin in patients aged ≥65 years with hepatorenal syndrome using data from 3 Phase ...
Muhammad A. Mujtaba, Ann Kathleen Gamilla-Crudo, Shehzad N. Merwat, Syed A. Hussain, Michael Kueht, Aftab Karim, Muhammad W. Khattak, Peggy J. Rooney, Khurram Jamil   +8 more
doaj   +1 more source

Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study

International Journal of Nephrology, 2015
Background/Aims. Acute kidney injury is a common problem for patients with cirrhosis and is associated with poor survival. We aimed to examine the association between type of acute kidney injury and 90-day mortality. Methods.
Andrew S. Allegretti, Guillermo Ortiz, Julia Wenger, Joseph J. Deferio, Joshua Wibecan, Sahir Kalim, Hector Tamez, Raymond T. Chung, S. Ananth Karumanchi, Ravi I. Thadhani   +9 more
doaj   +1 more source

HEPATORENAL SYNDROME: DIAGNOSTIC AND THERAPEUTIC MANAGEMENT

Alʹmanah Kliničeskoj Mediciny, 2016
The practical guidelines on diagnosis and management of hepatorenal syndrome, which could be useful for general medical practitioners, gastroenterologists, and hepatologists, are considered in this paper.
I. G. Bakulin, A. A. Varlamicheva
doaj   +1 more source

Hepatorenal syndrome: Updates. [PDF]

Clin Liver Dis (Hoboken), 2023
Tiwari N, Wong F.
europepmc   +3 more sources

Serum microRNA-122 predicts survival in patients with liver cirrhosis [PDF]

, 2012
Background: Liver cirrhosis is associated with high morbidity and mortality. MicroRNAs (miRs) circulating in the blood are an emerging new class of biomarkers.
Brunner, Friederike, Kronenberger, Bernd, Köberle, Verena, Piiper, Albrecht, Waidmann, Oliver, Zeuzem, Stefan   +5 more
core   +3 more sources

A rare and threatening complication in a cirrhotic patient [PDF]

, 2018
info:eu-repo/semantics ...
Anapaz, V, Branco, J, Reis, J, Santos, L
core   +1 more source